According to the Global Times, a booster vaccine against COVID-19, that is inhaled, was being distributed in Shanghai on Wednesday, October 26.
A person with the surname Shen told the Global Times, “The whole process is very convenient. It also tastes a little bit sweet.”
The Global Times also reported that authorities said that people who had received all their previous shots at least six months ago and were at least 18 years old would receive a free inhaler shot.
The “zero-COVID” policy, which depresses the Chinese and international economy and places severe restrictions on freedoms, shows that Sinopharm’s vaccines, Sinovac and CanSino, were not effective in combating the virus.
He Jinhui, a nurse at the Hospital of Traditional Chinese Medicine, Tianshan, Changning District, Shanghai, said, “Before vaccination, I will give them instructions on how the process works and there is also a poster here to guide the residents.”
He added, “Exhale deeply first, hold the mouth of the atomizer and inhale the vaccine, then hold your breath for at least five seconds, before regular breathing.” She went on to say that people should not take the vaccine on an empty stomach and also advised drinking more water after getting the vaccine.
The whole process of inhaling a gas with old-fashioned Ad5-nCoV technology takes 20 seconds and is only used in China.
Chinese citizens are wary of COVID vaccines
In Shanghai, 23 million have been fully vaccinated and of those, more than 12 million have received booster shots, but only 79 individuals have used the CanSino Biologics inhaler, and this calls into question the entire “effort” of the Chinese regime against omicron.
However, the inhaler vaccine is the first of its kind, and wins the race against Bharat Biotech’s nasal drops.
Research shows that respiratory droplets and close-contact transmission are still the main vehicles of getting COVID. Putting a vaccine between the virus and the body would place the vaccine at “first point of contact.” It would be “like putting on an invisible mask,” CanSino Biologics told Global Times.
According to the company’s report, the booster inhaler is highly immunogenic as it develops an antibody level 14 times higher against SARS-CoV-2 than the intramuscular vaccine.
The People’s Liberation Army Academy of Medical Sciences, accused of chemical and biological weapons production by the Biden administration, is also studying messenger RNA technology.
The CanSino Biologics serum, however, was approved as a booster by the World Health Organization (WHO) in May 2022, despite the secrecy of clinical trials and suspicion about military laboratories.
The world looks on in amazement at China’s ‘zero-COVID’ policy
According to Dr. Collin Koh of the Rajaratnam School of International Studies in Singapore, “The average Chinese citizen will feel that things are not going very well, so there is a need to reinvigorate the kind of growth that China has been more used to in recent decades.”
And he said, “The CCP’s political legitimacy lies in socioeconomic delivery.”
Many analysts no longer doubt the failure of the Chinese economic miracle, after Xi’s words during the 20th Congress, where he said that there will be more “zero-COVID” policy, use of military force against Taiwan id necessary, and eliminating freedoms in Hong Kong.
All of this is a challenge to the United States, which sees the One Belt One Road initiative and claims in the South China Sea as its main external threat.
It seems that Xi has been chosen by providence to destroy the CCP, as Leonid Brezhnev once did at the helm of the Soviet Union.
The CCP is wary of its vaccines and wants to buy time to manufacture messenger RNA platform serums.
Simon Chen, professor of political science at National Taiwan University, said that “Even though everyone can see that economic growth has slowed, [Xi] still wants to persist in his ‘zero-COVID.”
Many analysts believe that the anti-COVID program is due to Xi’s lack of confidence in his vaccines.
The truth is that this shutdown of the Asian Giant’s economy is contributing to global supply chain shortages and delaying the recovery of the international aviation and tourism sectors.